IDXX - Company ID 0000874716
The table below shows IDEXX LABORATORIES INC /DE's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $4.30B | $3.90B | $3.66B | $3.37B | $3.22B | $2.71B |
| Cost of revenue | $1.64B | $1.52B | $1.47B | $1.36B | $1.33B | $1.14B |
| Gross profit | $2.66B | $2.38B | $2.19B | $2.00B | $1.89B | $1.57B |
| R&D | $251.21M | $219.79M | $190.95M | $254.82M | $161.01M | $141.25M |
IDEXX LABORATORIES INC /DE reported annual revenue of $4.30B for fiscal year 2025. That is up 10.4% from $3.90B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.78B (FY 2016) to $4.30B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $404.79M |
| $442.29M |
| $335.82M |
| $326.25M |
| $309.66M |
| $300.83M |
| Operating income | $1.36B | $1.13B | $1.10B | $898.76M | $932.03M | $694.52M |
| Income tax | $264.73M | $221.96M | $216.13M | $180.88M | $157.81M | $79.85M |
| Net income | $1.06B | $887.87M | $845.04M | $679.09M | $744.85M | $581.78M |
| EPS (diluted) | $13.08 | $10.67 | $10.06 | $8.03 | $8.60 | $6.71 |